IN-SILICO EVALUATION OF TETRAMETHYL-PYRAZINE: TREATING RECURRING SEIZURES
Abstract
Epilepsy, a chronic neurological disorder characterized by recurrent seizures, remains a challenging condition to treat due to the limited availability of potent and safe molecules. This study explores Tetramethyl-pyrazine (TMP) as a potential scaffold for epilepsy treatment, leveraging its diverse pharmacological properties. Utilizing structure-based virtual screening, we identified 300 active ligands from a virtual chemical library of 4427 compounds, narrowing down to the top 7 potential ligands for GABA-AT inhibitor properties based on binding energy, drug-likeness, non-covalent interactions, and toxicity. Our results revealed a compound (PubChem ID 227746) with high binding affinity to protein 4MS4, strong interactions within the active site, and favorable pharmacokinetic and toxicological properties, suggesting TMPz holds promise as an anti-epileptic agent.
Downloads
All the articles published in JAPSR are distributed under a creative commons license (CC BY-NC-SA 4.0)
Under this license, you are free to:
- Share- copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt- remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes .
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Copyright policy
The journal allows the author(s) to hold the copyright of their work. That means the authors do not need to transfer the copyright of their work to the journal. However, the authors grant JAPSR a license to publish the article and identify itself as the original publisher.
Licensing policy
The journal allows the author(s) to hold the copyright of their work. That means the authors do not need to transfer the copyright of their work to the journal. However, the authors grant JAPSR a license to publish the article and identify itself as the original publisher.